课题基金 / 基金详情

Genomic determinants of common long-term treatment effects in childhood acute lymphoblastic leukemia survivors

Genomic determinants of common long-term treatment effects in childhood acute lymphoblastic leukemia survivors
儿童急性淋巴细胞白血病幸存者常见长期治疗效果的基因组决定因素
批准号：
234947
负责人：
Sinnett Daniel
金额：
$178.12万
依托单位：
Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-06-01 至 2016-06-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=234947&lang=en
关键词：
Biostatistics Bone Morbidity Cancer Survivorship Cardiotoxicity Childhood Leukemia Long-Term Disease Outcomes/Biomarkers Medical Genomics Metabolic Syndrome Neurocognition Next-Generation Sequencing/Dna Variants

项目摘要

项目成果

Sinnett Daniel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acute lymphoblastic leukemia (ALL) is the most frequent cancer in children, accounting for approximately 25% of all pediatric tumors. Advances in our understanding of the pathobiology of this cancer and of its treatment have led to increased survival rate
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CircRNAome in childhood TCF3-PBX1 ALL: Biomaker potential and mechanisms of circRNA dysregulation and function
Investigation of the genomic determinants of childhood leukemia using next-generation sequencing
Genomic determinants of common long-term treatment effects in childhood acute lymphoblastic leukemia survivors
Genomic determinants of childhood leukemia
海外基金